Select Medical Holdings (SEM)
Official siteMEDICAL CARE FACILITIES
Last updated: Jul 01, 2026 at 5:00 PM ET
Select Medical Holdings (SEM) Financials: Revenue, Profit and Cash Flow
Select Medical Holdings reported revenue of $5.45B for the fiscal year ended Dec 31, 2025, up 5.1% from the year before. That year, net income was $214.53M with a net margin of 3.9%, operating cash flow was $346.47M and free cash flow was $117.24M. The quarter ended Mar 31, 2026 had revenue of $1.42B and net income of $63.77M.
Revenue and Margins
The operating margin was 6.2% in the fiscal year ended Dec 2025. Over the 9 years to Dec 2025, revenue grew from $4.22B, a compound annual rate of 2.9%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | $5.45B | +5.1% | 11.5% | 6.2% | 3.9% |
| Dec 2024 | $5.19B | +7.5% | 12.2% | 5.2% | 5.7% |
| Dec 2023 | $4.83B | +4.7% | 11.8% | 5.5% | 6.2% |
| Dec 2022 | $4.61B | -25.7% | 8.7% | 3.1% | 4.3% |
| Dec 2021 | $6.20B | +12.2% | 14.8% | 11.5% | 8.1% |
| Dec 2020 | $5.53B | +1.4% | 14.8% | 10.3% | 6.2% |
| Dec 2019 | $5.45B | +7.3% | 14.9% | 8.7% | 3.7% |
| Dec 2018 | $5.08B | +16.4% | 14.6% | 8.2% | 3.5% |
| Dec 2017 | $4.37B | +3.5% | 14.4% | 8.2% | 5.1% |
| Dec 2016 | $4.22B | N/A | 13.1% | 7.1% | 3.0% |
Income Statement
In the fiscal year ended Dec 2025, net income fell 27.7% from the year before. In the quarter ended Mar 2026, net income fell 14.7% from the same quarter a year earlier.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.45B | $5.19B | $4.83B | $4.61B | $6.20B | $5.53B | $5.45B | $5.08B | $4.37B | $4.22B |
| Cost of revenue | $4.82B | $4.55B | $4.25B | $4.21B | $5.29B | $4.71B | $4.64B | $4.34B | $3.74B | $3.67B |
| Gross profit | $629.29M | $633.64M | $571.61M | $401.49M | $919.37M | $821.34M | $812.92M | $740.20M | $629.94M | $552.09M |
| Operating income | $336.17M | $268.31M | $267.24M | $144.75M | $713.77M | $567.66M | $471.88M | $417.28M | $355.88M | $299.85M |
| Net income | $214.53M | $296.70M | $299.73M | $198.03M | $499.95M | $344.61M | $201.03M | $176.94M | $220.65M | $125.27M |
| EBITDA | $479.61M | $475.17M | $478.63M | $352.85M | $920.79M | $787.89M | $702.55M | $641.06M | $526.97M | $503.46M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.42B | $1.40B | $1.36B | $1.34B | $1.35B | $1.31B | $1.27B | $1.28B | $1.32B | -$179.22M | $1.67B | $1.67B |
| Gross profit | $175.47M | $145.83M | $147.45M | $155.45M | $180.56M | $137.47M | $135.87M | $159.81M | $200.50M | -$148.66M | $223.19M | $250.93M |
| Operating income | $98.42M | $63.94M | $72.96M | $86.53M | $112.75M | $21.09M | $54.90M | $73.86M | $118.47M | -$173.38M | $129.96M | $159.20M |
| Net income | $63.77M | $37.74M | $44.18M | $57.88M | $74.73M | $3.76M | $81.02M | $94.77M | $117.17M | $61.80M | $60.82M | $91.86M |
Balance Sheet
As of Dec 2025, total debt of $1.83B exceeded cash and equivalents by $1.80B.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $5.85B | $5.61B | $7.69B | $7.67B | $7.36B | $7.66B | $7.34B | $5.96B | $5.13B | $4.92B |
| Current assets | $1.03B | $1.02B | $1.26B | $1.27B | $1.14B | $1.59B | $1.21B | $992.52M | $920.83M | $762.90M |
| Cash and equivalents | $26.52M | $59.69M | $52.63M | $97.91M | $74.31M | $577.06M | $335.88M | $175.18M | $122.55M | $99.03M |
| Total liabilities | $3.82B | $3.61B | $6.12B | $6.27B | $6.00B | $6.00B | $5.44B | $4.27B | $3.55B | $3.59B |
| Short-term debt | $24.22M | $20.27M | $68.87M | $44.35M | $17.57M | $12.62M | $25.17M | $43.87M | $22.19M | $13.66M |
| Long-term debt | $1.80B | $1.69B | $3.58B | $3.84B | $3.56B | $3.39B | $3.42B | $3.25B | $2.68B | $2.69B |
| Shareholder equity | $1.71B | $1.68B | $1.29B | $1.12B | $1.11B | $1.06B | $770.97M | $803.04M | $823.37M | $815.73M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $6.04B | $5.85B | $5.69B | $5.74B | $5.70B | $5.61B | $8.00B | $7.88B | $7.86B | $7.69B | $7.68B | $7.70B |
| Total liabilities | $3.94B | $3.82B | $3.67B | $3.74B | $3.65B | $3.61B | $5.70B | $6.14B | $6.19B | $6.12B | $6.13B | $6.17B |
| Cash and equivalents | $25.68M | $26.52M | $60.05M | $52.35M | $53.21M | $59.69M | $191.47M | $111.16M | $92.62M | $52.63M | $77.44M | $101.17M |
| Shareholder equity | $1.76B | $1.71B | $1.69B | $1.67B | $1.72B | $1.68B | $1.92B | $1.42B | $1.37B | $1.29B | $1.27B | $1.25B |
Cash Flow
In the fiscal year ended Dec 2025, free cash flow was 33.8% of operating cash flow. Dividends and share repurchases together came to 188.8% of it.
Annual
| Line item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $346.47M | $517.86M | $582.06M | $284.82M | $401.23M | $1.03B | $445.18M | $494.19M | $238.13M | $346.60M |
| Capital expenditures | $229.22M | $222.18M | $229.20M | $190.37M | $180.54M | $146.44M | $157.13M | $167.28M | $233.24M | $161.63M |
| Free cash flow | $117.24M | $295.69M | $352.86M | $94.45M | $220.69M | $881.63M | $288.06M | $326.91M | $4.89M | $184.97M |
| Dividends paid | $121.32M | $124.62M | $127.44M | $107.70M | $123.68M | $38.59M | $21.78M | $311.52M | $10.62M | $3.74M |
| Share repurchases | $100.08M | $37.91M | $19.03M | $201.40M | $740.13M | $592.40M | $38.53M | $6.84M | $4.75M | $2.93M |
| Investing cash flow | -$216.49M | -$231.01M | -$268.48M | -$226.34M | -$256.59M | -$115.35M | -$316.73M | -$697.14M | -$192.97M | -$554.32M |
| Financing cash flow | -$163.15M | -$311.17M | -$327.48M | -$34.89M | -$647.38M | -$671.54M | $32.25M | $255.57M | -$21.65M | $292.31M |
Quarterly
| Line item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $37.86M | $64.33M | $175.31M | $110.29M | -$3.46M | $125.43M | $180.97M | $278.15M | -$66.69M | $179.44M | $116.34M | $234.84M |
| Capital expenditures | $58.90M | $59.10M | $53.10M | $64.68M | $52.34M | $63.43M | $50.68M | $55.55M | $52.52M | $60.60M | $50.20M | $59.51M |
| Free cash flow | -$21.04M | $5.22M | $122.20M | $45.61M | -$55.80M | $62.00M | $130.29M | $222.60M | -$119.21M | $118.84M | $66.14M | $175.32M |
Frequently Asked Questions About SEM
What is Select Medical Holdings' annual revenue?
Select Medical Holdings reported revenue of $5.45B for the fiscal year ended Dec 31, 2025.
How fast is Select Medical Holdings' revenue growing?
Revenue was up 5.1% for the fiscal year ended Dec 31, 2025 compared with the year before. The compound annual revenue growth rate over 3 years was 5.8%.
Is Select Medical Holdings profitable?
Yes. Select Medical Holdings reported net income of $214.53M for the fiscal year ended Dec 31, 2025, with a net margin of 3.9%.
How much free cash flow does SEM generate?
For the fiscal year ended Dec 31, 2025, operating cash flow of $346.47M minus capital expenditures of $229.22M produced free cash flow of $117.24M.
How much debt does Select Medical Holdings have?
The balance sheet dated Dec 31, 2025 reported long-term debt of $1.80B, short-term debt of $24.22M and cash and equivalents of $26.52M.
SEM pages: Overview, Dividends, Financials